The overall goal of this proposed research is to assign a role in hepatocarcinogenesis of each of several? genetic changes commonly identified in human and/or mouse liver tumors. To accomplish this objective, a? newly developed, novel in vivo assay system is employed, the comparative hepatocyte growth assay. As? starting material, this assay uses rodents that have been genetically modified to reflect activation of? proposed carcinogenic pathways. Hepatocytes are isolated from these animals, and then transplanted into? liver of specially designed recipient mice with liver disease that support transient replication of donor? hepatocytes: Evaluation of the subsequent clonal growth of donor cells in the new host environment allows? quantification of the influence of single or combined genetic modifications on (1) the rate at which? hepatocytes proliferate under growth stimulatory conditions; (2) the capacity for sustained hepatocyte growth? in a quiescent liver environment; and (3) the risk for hepatocyte progression to malignant transformation.? Each measure reflects an important characteristic of neoplastic cells. The quantitative nature of the data.? provides a more refined understanding of the specific contribution of each genetic change, alone and in? combination with others, to hepatocarcinogenesis. The final objective is to use this system as a tool for? cancer gene discovery, by correlating changes in patterns of gene expression with the changes in? hepatocyte clonal growth that will be identified. The proposal has the following specific aims.
Aim 1 : Define? the effects of specified combinations of gene changes on mouse hepatocarcinogenesis.
Aim 2 : Quantify? effects of defined gene changes on hepatocyte growth and transformation frequency in vivo.
Aim 3 : Identify? growth characteristics and changes in the pattern of gene expression of transformed hepatocytes in vivo.? Successful completion of these experiments will (1) define specific interactions between several highly? relevant genetic changes (synergistic or additive complementation, or no complementation) during hepatic? carcinogenesis; (2) provide a systematic and comparative evaluation of the influence of genetic and? environmental alterations, selected for their relevance to liver cancer, on hepatocyte growth potential; and (3)? will identify gene sets that cooperate with oncogenes during tumor progression.
Showing the most recent 10 out of 258 publications
